Outcomes for a multi-institutional cohort of patients treated with intra-operative radiation therapy for advanced or recurrent renal cell carcinoma.
Jonathan J. Paly(Harvard University), Jason A. Efstathiou(Massachusetts General Hospital), Andrzej Niemierko(Harvard University), Felipe A. Calvo(Hospital General Universitario Gregorio Marañón), Falk Roeder(Heidelberg University), Christopher L. Hallemeier(Mayo Clinic in Arizona), Gerd Fastner(Dana-Farber Cancer Institute), Jared M. Whitson(University of California, San Francisco), Rodney J. Ellis(Pennsylvania State University), Rafael Martínez‐Monge(Navarre Institute of Health Research), William W. Wong(Mayo Clinic in Arizona), Peter J. Biggs(Massachusetts General Hospital)
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Oesophageal cancer
|The Lancet|2024|265